Acquisition and Equity-Method Investment (Tables)

3 Months Ended

Mar. 29, 2020

Business Combinations, Disposal Groups, Including Discontinued Operations, Equity Method Investments And Research And Development Arrangement [Abstract]

Equity Method Investment

Summarized financial information for our equity method investee, GSK Consumer Healthcare, as of and for the three months ending December 31, 2019, the most recent period available, is as follows:
(MILLIONS OF DOLLARS)	December 31, 2019
Current assets	$	7,537
Noncurrent assets	39,509
Total assets	$	47,046
Current liabilities	$	5,576
Noncurrent liabilities	5,321
Total liabilities	$	10,898
Equity attributable to shareholders	$	36,029
Equity attributable to noncontrolling interests	120
Total net equity	$	36,149

(MILLIONS OF DOLLARS)	Three Months Ended December 31, 2019
Net sales	$	3,188
Cost of sales	(1,811		)
Gross profit	$	1,377
Income from continuing operations	46
Net income	46
Income attributable to shareholders	37